Perrigo (PRGO)
(Real Time Quote from BATS)
$27.74 USD
-0.17 (-0.61%)
Updated Jul 24, 2024 11:22 AM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Price, Consensus and EPS Surprise
PRGO 27.74 -0.17(-0.61%)
Will PRGO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for PRGO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PRGO
Why Is Perrigo (PRGO) Down 15.1% Since Last Earnings Report?
Understanding Perrigo (PRGO) Reliance on International Revenue
PRGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates
Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Other News for PRGO
O'Keefe Stevens Advisory Q2 2024 Investor Letter
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
Former Wendy’s CEO Joins Dutch Bros Board of Directors
PRGO February 2025 Options Begin Trading